Bausch & Lomb Corp (BLCO) stock
BLCONYSEOphthalmic GoodsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 9/3029% below fair value
$20.83−0.05 (-0.24%)
Close on Nov 17, 2026Market cap $7.45BP/E –Yield –
Bausch & Lomb price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Bausch & Lomb's price to sales ratio was 1.4× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.8× to 1.8×, with a median of 1.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.4× | +0.2 |
| 2025 | Dec 31, 2025 | 1.2× | −0.1 |
| 2024 | Dec 31, 2024 | 1.4× | −0.2 |
| 2023 | Dec 29, 2023 | 1.5× | +0.1 |
| 2022 | Dec 30, 2022 | 1.4× | – |
See a number that looks wrong?